Monash ranked #4 in world for Pharmacy and Pharmacology
22 March 2016
The 2016 QS World University Rankings by Subject, released overnight, have confirmed Monash University's position as a global leader in the fields of Pharmacy and Pharmacology.
Monash, which has averaged in the top ten over the past five years, is this year ranked fourth equal in the world, a position shared with King's College London.
The result places the Faculty of Pharmacy and Pharmaceutical Sciences at number one in Australia and the Asia Pacific, and is the highest rank in any discipline of any university in Australia. Worldwide, it is topped only by Harvard University, University of Cambridge and University of Oxford. Monash's partners in PharmAlliance, the University of North Carolina at Chapel Hill and University College London, also featured in the top ten.
The rankings based on series of quantitative and qualitative measures. They are compiled from evaluations of 4,226 universities and take into account 113 million citations and attributions.
"The quality of the educational and research output of any institution will always defy precise quantification. Nonetheless, rankings like this provide a useful indicator of how the faculty measures up against its peers. The number four spot is a wonderful recognition of our talented staff, and the hard work they do to address major healthcare challenges domestically and internationally," said Professor Bill Charman, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences.
Monash's placement in the QS is mirrored in the recent news that the University of North Carolina at Chapel Hill has been named top pharmacy school in the US by the US News & World Report. Alongside University College London, UNC at Chapel Hill is one of Monash's partners in PharmAlliance, the research, education and practice partnership between three of the world's most highly-regarded schools of pharmacy,
The rankings news also comes hot on the heels of the news late last year that six researchers affiliated with the faculty were named to the Thompson Reuters Hi-Ci list, which identifies those researchers whose work falls in top 1% of the most cited papers worldwide.
It follows success in the most recent round of the Excellence in Research for Australia (ERA) rankings. Monash achieved the highest possible score of "5" (meaning its research was well above world standard) in the research discipline areas of Pharmacology and Pharmaceutical Sciences, Medicinal and Biomolecular Chemistry, and Nanotechnology.